Gary M. Phillips
CIK 1197795 · Exec. VP & Chief Strategy Ofcr · last filed 2026-06-11
Gary M. Phillips is an Exec. VP & Chief Strategy Ofcr who has filed 33 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for ALDX, was dated Jun 11, 2026. Across all open-market trades the lifetime net is +$72.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $26.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$26.1K
4
33
$72.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALDX | Director | 14,812 | $1.76 | $26.1K | $0 | 13 | 2026-06-11 |
| Keenova Therapeutics plc (MNK) Delisted | Exec. VP & Chief Strategy Ofcr | 21,641 | $0.34 | $7.4K | $72.2K | 8 | 2018-01-05 |
| ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted | Director | — | — | — | $0 | 3 | 2017-06-21 |
| BAUSCH & LOMB INC (BOL) Delisted | Vice President | 14,459 | — | — | $0 | 5 | 2007-09-25 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2023-09-11 | ALDX | Exer (M) | +5,437 | $3.0K | EDGAR |
| 2023-07-05 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2021-06-10 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2020-05-21 | — | Disp (D) | −33,620 | $0 | |
| 2020-03-05 | — | Grant (A) | +13,620 | $0 |